Cover [Abstract] Document Information [Table] Document Information [Line Items] Document Type Document Quarterly Report Document Quarterly Report Document Period End Date Document Transition Report Document Transition Report Entity Registrant Name Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Title of 12(g) Security Title of 12(g) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable (net of allowance for expected credit losses of $442 and $118 as of June 30, 2023 and December 31, 2022, respectively) Inventory, Net Inventory Total inventory Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Restricted Cash, Noncurrent Restricted cash Property, Plant and Equipment, Net Property and equipment, net Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Other Assets, Noncurrent Other non-current assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Employee Benefits, Current Accrued compensation and benefits Amount of expenses incurred but not yet paid classified as other, and other liabilities due within one year or the normal operating cycle, if longer. Accrued Expenses And Other Liabilities, Current Accrued expenses and other current liabilities Total accrued expenses and other current liabilities Contract with Customer, Liability, Current Deferred revenue Operating Lease, Liability, Current Operating lease liabilities Liabilities, Current Total current liabilities Contract with Customer, Liability, Noncurrent Deferred revenue, net of current portion Operating Lease, Liability, Noncurrent Lease liabilities, net of current portion Other Liabilities, Noncurrent Other non-current liabilities Liabilities Total liabilities Commitments and Contingencies. Commitments and contingencies (Note 12) Commitment to sponsor agreement Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock, $0.001 par value, per share: Authorized shares: 120,000; Issued and outstanding: 37,566 and 37,280 shares at June 30, 2023 and December 31, 2022, respectively Additional Paid in Capital, Common Stock Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Ending Balance Beginning Balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Allowance for Doubtful Accounts Receivable, Current Ending Balance Beginning Balance Accounts receivable, reserve for doubtful accounts Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, authorized shares Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding CONSOLIDATED STATEMENTS OF OPERATIONS Product and Service [Axis] Products and Services [Domain] Product revenue Product revenue Service revenue Service revenue Service revenue. Service revenue. Collaboration and license revenue Collaboration and license revenue Grant revenue Revenues [Abstract] Revenues: Revenue from Contract with Customer, Excluding Assessed Tax Total revenues Revenue Cost of Goods and Services Sold [Abstract] Costs of goods sold and services: Cost of Revenue Cost of revenue Total costs of goods sold and services Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development Selling, General and Administrative Expense Selling, general, and administrative The amount of other lease costs incurred during the reporting period. Other Lease Costs Other lease costs Restructuring Charges Restructuring Goodwill, Impairment Loss Goodwill impairment Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Interest Income (Expense), Net Interest income, net Other Nonoperating Income (Expense) Other expense, net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Income Tax Expense (Benefit) Income tax (expense) benefit Net loss Net loss Net income (loss) per share, basic Net loss per common share, basic (in dollars per share) Basic net (loss) income per share Net Income (Loss) Available to Common Stockholders, Diluted Net loss per common share, diluted (in dollars per share) Diluted net (loss) income per share Weighted Average Number of Shares Outstanding, Basic Weighted-average common shares outstanding, basic (in shares) Basic weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted Weighted-average common shares outstanding, diluted (in shares) Diluted weighted average common shares outstanding CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Other Comprehensive Income (Loss), Net of Tax [Abstract] Other comprehensive loss: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Foreign currency translation Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Total other comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Common stock Additional paid-in capital Accumulated other comprehensive income (loss) Accumulated deficit Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity Shares, Outstanding Ending Balance (in shares) Beginning balance (in shares) Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Issuance of common stock under stock plans, including tax effects Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Issuance of common stock under stock plans, including tax effects (in shares) Stock Issued During Period, Value, Stock Options Exercised Exercised stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised (in shares) Exercised stock options (in shares) Stock Issued During Period, Value, Employee Stock Purchase Plan ESPP stock purchase Stock Issued During Period, Shares, Employee Stock Purchase Plans Employee stock purchase plan (in shares) ESPP stock purchase (in shares) Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation expense CONSOLIDATED STATEMENT OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Amortization and Accretion, Net Depreciation and amortization expense Accounts Receivable, Credit Loss Expense (Reversal) Credit losses on accounts receivable Foreign Currency Transaction Loss, before Tax Foreign currency losses Operating Lease, Right-of-Use Asset, Periodic Reduction Operating lease right-of-use asset amortization Share-based Compensation Stock-based compensation expense Deferred Income Taxes and Tax Credits Deferred income taxes Gain (Loss) on Disposition of Property Plant Equipment Loss on disposal of fixed assets Increase (Decrease) in Operating Capital [Abstract] Changes in assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Other Noncurrent Assets Other non-current assets Increase (Decrease) in Accounts Payable, Trade Accounts payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued compensation and benefits, accrued expenses and other current liabilities Increase (Decrease) in Deferred Revenue Deferred revenue Deferred revenue The increase (decrease) during the reporting period in the aggregate amount of lease liabilities. Increase Decrease In Operating Lease Liabilities Operating lease liabilities Increase (Decrease) in Other Noncurrent Liabilities Other non-current liabilities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment The cash inflow from grants for asset purchase. Proceeds From Grant For Asset Purchase Proceeds from RADx grant on assets purchased Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Proceeds from common stock issued under stock plans Payment, Tax Withholding, Share-Based Payment Arrangement Payments for employee taxes on units withheld Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Net decrease in cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Effect of exchange rate changes on cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents, and restricted cash at end of period Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash Supplemental disclosure of cash flow information: Income Taxes Paid Cash paid for taxes Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Operating lease right-of-use assets obtained in exchange for lease liabilities Amount of shares received in exchange of license of intellectual property in noncash investing or financing activities. Shares Received in Exchange for License of Intellectual Property Shares received in exchange for license of intellectual property (Note 3) Organization and Nature of Business Nature of Operations [Text Block] Organization and Nature of Business Significant Accounting Policies Significant Accounting Policies [Text Block] Significant Accounting Policies Revenue and Related Matters Revenue from Contract with Customer [Text Block] Revenue and Related Matters Allowance for Credit Losses Allowance for Credit Losses [Text Block] Allowance for Credit Losses Fair value of financial instruments Fair Value Disclosures [Text Block] Fair value of financial instruments Inventory Inventory Disclosure [Text Block] Inventory No definition available. Accrued Expenses and Other Current Liabilities The entire disclosure of information pertaining to Accrued liabilities and other current liabilities. Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Expenses and Other Current Liabilities Stock-Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Compensation Net Loss Per Share Earnings Per Share [Text Block] Net Loss Per Share Income Taxes Income Tax Disclosure [Text Block] Income Taxes No definition available. Goodwill. Goodwill Disclosure [Text Block] Goodwill Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Related Party Transactions Related Party Transactions Disclosure [Text Block] Related Party Transactions Restructuring Restructuring and Related Activities Disclosure [Text Block] Restructuring No definition available. Variable Interest Entities Variable Interest Entity Disclosure [Text Block] Variable Interest Entities Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Presentation of Restricted Cash New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Service Revenue Restrictions on Cash and Cash Equivalents [Table Text Block] Schedule of cash and cash equivalents Disaggregation of Revenue [Table Text Block] Schedule of disaggregated revenue Tabular disclosure of changes in deferred revenue from contracts with customers. Schedule of Changes in Deferred Revenue from Contracts with Customers [Table Text Block] Schedule of changes in deferred revenue from contracts with customers Capitalized Contract Cost [Table Text Block] Schedule of costs to obtain a contract Accounts Receivable, Allowance for Credit Loss [Table Text Block] Schedule of the allowance for credit losses Fair Value, by Balance Sheet Grouping [Table Text Block] Schedule of fair value measurements Schedule of Inventory, Current [Table Text Block] Summary of inventory Tabular disclosure for accrued liabilities and other current liabilities. Accrued Liabilities and Other Liabilities Current [Table Text Block] Summary of Accrued expenses and other current liabilities Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Summary of share-based compensation expense for all stock awards Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of stock option activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Summary of restricted stock units activity Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options and employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. Schedule of Share-Based Payment Award, Stock Options and Employee Stock Purchase Plan,Valuation Assumptions [Table Text Block] Summary of fair value of the Company's stock options granted and purchase rights to the ESPP Schedule of basic and diluted shares Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of common share equivalents have been excluded from the calculation of diluted net loss per share Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Commitments and contingencies Collaboration and license arrangements Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of future minimum lease payments Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Schedule of rollforward of the restructuring reserve and provision activity Schedule of Stock by Class [Table] Statistical Measurement [Axis] Range [Domain] Minimum Class of Stock [Line Items] Organization and Nature of Business Number of projects completed by the entity Entity Number of Projected completed Number of customers served using simoa platforms by the entity. Entity Number of Customers Served Schedule of Cash and Cash Equivalents [Table] Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents Cash and Cash equivalents Restricted Cash and Cash Equivalents Restricted cash (1) This member stands for revenue relating to instrument products. Instruments This member stands for revenue relating to consumable and other products. Consumable and other products Represents the information pertaining to research services. Research services This member stands for revenue relating to other services. Other services Represents the information pertaining to service-type warranties. Service-type warranties Geographical [Axis] Geographical [Domain] NA North America EMEA EMEA Asia Pacific Asia Pacific Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Arrangements and Non-arrangement Transactions [Domain] Represents information relating to collaboration agreement. Collaboration agreement Represents information relating to master collaboration agreement. Master collaboration agreement Represents information relating to statement of work agreement. Statement of works agreement Counterparty Name [Axis] Counterparty Name [Domain] Represents information relating to Eli Lilly. Eli Lilly Concentration Risk Type [Axis] Concentration Risk Type [Domain] Customer Concentration Risk Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Revenue. Accounts Receivable Amount of non refundable upfront payment received. Collaborative Arrangement, Upfront Payment Received Non-refundable up-front payment received Amount of non refundable upfront payment received per quarter. Collaborative Arrangement, Payment Received Per Quarter Collaborative arrangement payment received per quarter Number Of Customers With High Percent Of Total Revenue Number Of Customers With High Percent Of Total Revenue Number Of Customers With High Percent Of Gross Accounts Receivable Number Of Customers With High Percent Of Gross Accounts Receivable Threshold percentage used for calculating concentration of risk. Threshold Used for Calculating Concentration of Risk Threshold limit used for calculating concentration risk percentage No definition available. Collaboration and license arrangements Represents information pertaining to Abbot license agreement. Abbot license agreement Related Party [Axis] Related Party [Domain] Represents information relating to UltraDx Limited company formed by ARCH Venture Partners in which company's director is affiliated. UltraDx Limited Company UltraDx Number of days notice to be given to terminate the agreement. Number of Days Notice to Terminate Agreement Number of days notice to terminate agreement Represents the initial license fee receivable under collaboration and license arrangements. Collaboration And License Arrangements, Initial License Fee Receivable Initial license fee receivable The amount that refers to consideration received on collaboration and license arrangements. Collaboration And License Arrangements, Consideration Received Consideration on collaboration activities Amount of contingent shares receivable in a collaboration and license agreement. Collaboration And License Arrangements, Contingent Share Amount Receivable Shares amount received Number of contingent shares received in a collaboration and license agreement. Collaboration And License Arrangements, Contingent Consideration, Shares Received, Number Number of contingent consideration collaboration Amount of proceeds from contingent amount of shares received in a collaboration and license agreement. Collaboration And License Arrangements, Proceeds from Contingent Consideration Total fair value Represents about Rapid Acceleration of Diagnostics (RADx) program workplan two. RADx WP2 Represents information relating to Alzheimer's Disease Diagnostic Fund grant from charitable venture philanthropy entity. Alzheimer's Disease Diagnostic Fund [Member] ADDF Represents information pertaining to national institutes of health (NIH). National Institutes of Health The amount of contract value. Contract Value Contract value Contract Payment Received Contract Payment Received Contract with Customer, Asset, after Allowance for Credit Loss Deferred Revenue, Revenue Recognized Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Represents the information pertaining to underlivered services related to initial and extended service-type warranties and research services. Undelivered licenses of intellectual property Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Transaction Price Allocated to Remaining Performance Obligations Revenue, Remaining Performance Obligation Amount of transaction price allocated to performance obligations Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Performance obligation satisfaction period Capitalized Contract Cost [Abstract] Change in the balance of costs to obtain a contract Capitalized Contract Cost, Net Balance at end of period Balance at beginning of period Decrease in capitalized contract costs due to deferral of costs to obtain a contract. Capitalized Contract Cost, Deferral of Costs to Obtain a Contract Deferral of costs to obtain a contract Addition of capitalized contract costs due to recognition of costs to obtain a contract. Capitalized Contract Cost, Recognition of Costs to Obtain a Contract Amortization of costs to obtain a contract Capitalized Contract Cost, Impairment Loss Impairment loss Provision for Loan, Lease, and Other Losses Provision for expected credit losses Amount of write off (recovery) in allowance for credit loss on accounts receivable. Accounts Receivable, Allowance for Credit Loss, Write off (Recovery) Write-offs and recoveries collected Fair Value, by Balance Sheet Grouping [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy [Domain] Level 1 Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Money market funds Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair value of financial instruments Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents - money market funds Assets, Fair Value Disclosure Total Financial Assets Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Changes in the Company's Level 3 financial instruments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Issuances Receipt of ordinary shares of UltraDx (Note 13) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Fair value Inventory, Raw Materials, Gross Raw Materials Inventory, Work in Process, Gross Work in process Inventory, Finished Goods, Gross Finished goods Accrued Professional Fees, Current Accrued professional services Accrued Royalties, Current Accrued royalties Taxes Payable, Current Accrued tax liabilities Carrying value as of the balance sheet date of obligations incurred through that date and payable for inventory. Accrued Inventory Accrued in-transit inventory Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued other cost. Accrued Other Cost Other accrued expenses Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock-based compensation Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding at the end of the period (in shares) Outstanding at the beginning of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Cancelled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested and expected to vest at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted-average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding at the end of the period (in dollars per share) Outstanding at the beginning of the period (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Cancelled (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested and expected to vest at the end of the period (in dollars per share) No definition available. Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract] Weighted-average remaining contractual life Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Exercisable at the end of the period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Vested and expected to vest at the end of the period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Exercisable at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Vested and expected to vest at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average fair value of options granted Weighted-average grant date fair value Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Period of recognition of unrecognized compensation cost Restricted stock units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Number of restricted stock units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Unvested restricted common stock at the end of the period (in shares) Unvested restricted common stock at the beginning of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Cancelled (in shares) The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are expected to convert as of the balance sheet date. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Expected To Convert, Number Expected to convert Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted-average grant date fair value per share Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Unvested restricted common stock at the end of the period (in dollars per share) Unvested restricted common stock at the beginning of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Cancelled (in dollars per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected to Convert Weighted Average Grant Date Fair Value Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected to Convert Weighted Average Grant Date Fair Value Expected to convert (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Unvested, Weighted-average remaining contractual life (in years) Expected to convert,Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms, Expected to Convert Expected to Convert, Weighted-average Remaining Contractual Life (in years) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Unvested, Aggregate intrinsic value Intrinsic value of award expected to convert under share-based payment arrangement. Excludes share and unit options. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Expected To Convert, Aggregate Intrinsic Value Expected to convert, Aggregate intrinsic value Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Total unrecognized compensation cost related to unvested stock awards Plan Name [Axis] Plan Name [Domain] This member stands for Employee Stock Purchase Plan (the 2017 ESPP). 2017 ESPP The annual increase in the number of shares available for issuance under the plan, represented as a percentage. Share Based Compensation Arrangement By Share Based Payment Award, Evergreen Provision, Annual Increase, Percentage Annual increase in the shares available for grant under the plan (as a percent of shares of common stock outstanding) The increase in number of shares available for issuance under the plan, as a result of evergreen provision. Share Based Compensation Arrangement By Share Based Payment Award, Evergreen Provision, Number Of Shares Increased Increase in the shares available for grant under the plan (in shares) Represents the information pertaining to restricted stock units and stock options. Restricted stock units and stock options Income Statement Location [Axis] Income Statement Location [Domain] This member stands for cost of product revenue. Cost of product revenue This member stands for cost of service and other revenue. Cost of service and other revenue Research and development Research and development Selling, general, and administrative Allocated Share-based Compensation Expense Share-based compensation expense Represents information relating to employee stock purchase plan purchase rights. Employee Stock Purchase Plan Awards [Member] Employee Stock Purchase Plan Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Fair value assumptions: Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest rate, Minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest rate, Maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, Minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, Maximum Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Information pertaining to unvested restricted common stock and restricted stock units. Common stock and RSUs Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of common share equivalents excluded in the calculation of diluted net loss per share Effective Income Tax Rate Reconciliation, Percent Goodwill [Roll Forward] Changes in the carrying value of goodwill Goodwill Goodwill Represents information pertaining to Stratec Supply Agreement. Stratec Supply Agreement Scenario [Axis] Scenario, Unspecified [Domain] Forecast The number of discs purchased. Number Of Discs Purchased Number of discs purchased The number of discs shipped. Number Of Discs Shipped Number of discs shipped Purchase Obligation Revenue from open purchase orders Other Commitment, to be Paid, Year One Purchase commitments expects to incur in next year Amount of cash inflow for the reimbursement of allowance of leased premises for tenant's occupancy. Tenant Improvements Allowances Reimbursement Tenant improvements allowances This member stands for tufts university. Tufts The member that stands for Harvard university. Harvard University This member stands for license agreements. License agreements No definition available. License Agreements [Abstract] License agreements Royalty Expense Royalty expense Upfront Fee Upfront Fee Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year 2023 (remainder) Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months 2024 Lessee, Operating Lease, Liability, Payments, Due Year Two 2025 Lessee, Operating Lease, Liability, Payments, Due Year Three 2026 Lessee, Operating Lease, Liability, Payments, Due Year Four 2027 Lessee, Operating Lease, Liability, Payments, Due Year Five 2028 Lessee, Operating Lease, Liability, Payments, Due after Year Five Thereafter Lessee, Operating Lease, Liability, Payments, Due Total lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed interest Total operating lease liabilities Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction Related party transactions Revenue from Related Parties Related party revenue Schedule of Restructuring and Related Costs [Table] Long-Lived Tangible Asset [Axis] Property, Plant and Equipment, Type [Domain] Property And Equipment [Member] Property And Equipment [Member] Software and Software Development Costs [Member] Goodwill [Member] Restructuring Cost and Reserve [Line Items] Restructuring Restructuring and Related Cost, Number of Positions Eliminated Total headcount Impairment, Long-Lived Asset, Held-for-Use Impairment of long-lived assets Restructuring Type [Axis] Type of Restructuring [Domain] Employee Severance [Member] Severance and Employee Benefit Costs Restructuring Reserve Balance at End of period Balance at Beginning of period Restructuring Reserve, Accrual Adjustment Accrual adjustments Payments for Restructuring Cash payments Restructuring Reserve, Foreign Currency Translation Gain (Loss) Foreign currency translation Consolidated Entities [Axis] Consolidated Entities [Domain] Variable Interest Entity, Not Primary Beneficiary Variable interest entities Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Ownership interest